Maria Jose T. C.
- Country
- Spain
- Department
- Oncology and Medical Hematology
Research Overview
- Dose-Escalation and Expansion Study of BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein Degrader, in Patients with B-Cell Malignancies
- Efficacy and Safety Evaluation of Glofitamab with Gemcitabine and Oxaliplatin Versus Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Efficacy of 16‑Week Omalizumab Monotherapy in Patients with Plant-derived Food Allergy Mediated by LTP and Profilin Sensitization
Data & Insights
Has run more than one trial at 301 of 530 partner sites.
Specializations
Lymphoma Expertise
Specializes in the treatment of various lymphoma subtypes, with particular focus on B-cell lymphomas and Hodgkin lymphoma. The investigator studies innovative therapeutic approaches for both newly diagnosed and relapsed/refractory cases.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Follicular Lymphoma
- Classical Hodgkin Lymphoma
- Peripheral T-Cell Lymphoma
Leukemia Research
Focuses on developing treatments for chronic lymphocytic leukemia (CLL) and related conditions. Investigates novel therapeutic combinations and targeted approaches for both treatment-naive and relapsed patients.
- CLL/Small Lymphocytic Lymphoma
- Richter's Syndrome
- B-Cell Malignancies
Therapeutic Approaches
Explores cutting-edge immunotherapy treatments and novel drug combinations. Specializes in evaluating targeted therapies including monoclonal antibodies and cell-based therapies.
- CAR T-Cell Therapy
- Targeted Molecular Therapies
- Combination Chemotherapy Regimens
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.